You just read:

Geneos Therapeutics Secures $10.5 Million in Series A Financing to Develop the Next Generation of Neoantigen-Targeting Cancer Immunotherapies

News provided by

Geneos Therapeutics, Inc.

Feb 21, 2019, 08:00 ET